Please find enclosed

October 28, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block, Bandra Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 SCRIP CODE: 543748 SYMBOL: AARTIPHARM Dear Sir/Madam, Sub: Intimation of Grant of Options under ‘APL Performance Stock Option Plan- 2023’ (“PSOP 2023’’) Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 This is to inform that the Nomination and Remuneration Committee of the Board of Directors of the Company at its meeting held today i.e. Wednesday, October 28, 2026 has approved grant of 850 (Eight Hundred and Fifty) stock options to certain eligible employees of the Company, under the APL Performance Stock Option Plan 2023 (PSOP 2023), subject to the provisions of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, at an exercise price of Rs. 5/- (Rupees Five Only) per option. Please take the same on your records. Thanking you, Yours faithfully, For AARTI PHARMALABS LIMITED JEEVAN MONDKAR COMPANY SECRETARY AND LEGAL HEAD ICSI M. NO. A22565